-
Task Force Project: 'The potential of anti-infectives as therapies for asthma and asthma exacerbations'
Infections play an important role in the development of asthma and as a trigger of asthma exacerbations. While there are many data regarding the role of viruses and other kind of microbes in asthma pathogenesis, there is little emphasis on the potential effectiveness of anti-infective agents in the treatment and prevention of asthma and asthma exacerbations.
The Infection and Allergy Interest Group has conducted 'The potential of anti-infectives as therapies for asthma and asthma exacerbations' Task Force Project in order to address this important clinical question that may become the basis of further guidelines on asthma and asthma exacerbation prevention and treatment.
Last updated: 22 February 2016 -
Infection & Allergy IG related presentations EAACI Congress 2014
Sunday
Plenary Symposium PL2 08:30 – 10:00
IgE paradigm in the immune system
Why is IgE formed?
Andreas Radbruch, Germany
Can we block the IgE-mediated response?
Ted Jardetsky, United States
IgE and parasitic disease
Maria Yazdanbakhsh, Netherlands
Symposium SYM 1 10:30 – 12:00
Explanations for the high prevalence of asthma and allergy
Influence of nutrition?
Influence of viruses?
James Gern, United States
Influence of bacteria?
Liam O'Mahony, Switzerland
Year in Review YIR 1 10:30 – 12:00
New treatment options for asthma
Targeting neutrophils
The role of antibiotics in asthma
Biologicals in asthma treatment
Symposium SYM 6 13:30 – 15:00
The natural history of allergy can be changed
T cells in the inception of allergy and asthma
Patrick Holt, Australia
Evolution of IgG and IgE responses in healthy vs allergic children
Paolo Matricardi, Germany
Early dietary intervention against allergy
Susanne Halken, Denmark
Symposium SYM 7 13:30 – 15:00
Epigenomics and metagenomics in allergy
Environment and methylation in asthma
Michael Kabesch, Germany
Systems biology and functional analysis of disease genes
Alexessander Couto Alves, United Kingdom
Perinatal programming of allergic disease: the role of intestinal flora
John Penders, Netherlands
Monday
Symposium SYM 18 10:45 – 12:15
Asthma treatment: beyond guidelines
Anticholinergics
Huib Kerstjens, Netherlands
Antibiotics
Guy Brusselle, Belgium
Biologicals
Thomas Casale, United States
Pro & Con PC 4 13:00 – 13:30
The microbiome is central for upper airways disease
PRO
Ruby Pawankar, Japan
CON
Philippe Gevaert, Belgium
Symposium SYM 20 13:45 – 15:15
Genetics of atopy
Which genes are responsible for asthma development?
William Cookson, United Kingdom
Is there a genetic risk factor for asthma exacerbations?
Fernando Martinez, United States
Comparative genetics applied for atopic dermatitis
Stephan Weidinger, Germany
Sister Society Symposium SSS 6 17:30 – 19:00
Allergy in Africa
Chair: Habib Douagui, Algeria
Chair: Michael Levin, South Africa
Education for allergic rhinitis: lessons from asthma care
Michael Levin, South Africa
Parasitic infections and asthma in Uganda
Harriet Mpairwe, Uganda
Tuesday
Meet the Expert MTE 14 07:30 – 08:15
Allergic bronchopulmonary aspergillosis
Allergic bronchopulmonary aspergillosis
Paul Greenberger, United States
Symposium SYM 28 10:30 – 12:00
Women in science. Mechanisms of asthma: lessons from farm environment studies
Chair: Antonella Muraro, Italy
Chair: Mübeccel Akdis, Switzerland
Effects of different farm environments on childhood asthma and allergies
Erika von Mutius, Germany
Business Meeting BM 16 10:30 – 12:00
Business Group IG Infection and Allergy
Lessons from the farm environment
Bianca Schaub, Germany
Sister Society Symposium SSS 7 13:30 – 15:00
WAF Symposium: Origins of Severe Airway Diseases
Chair: Nikos Papadopoulos, Greece
Chair: Lanny Rosenwasser, United States
Role of Viruses in Pediatric Asthma (Exacerbations and Development)
Peter Le Souef, Australia
Workshop WS 21 15:30 – 17:00
Mechanisms of viral bronchiolitis
Epithelial cells and innate cytokines
Thomas Eiwegger, Austria
Lung antigen-presenting cells
Jürgen Schwarze, United Kingdom
Neural mechanisms
Armin Braun, Germany
Wednesday
Workshop WS 22 10:30 – 12:00
Viral infections and drug hypersensitivity
Impact of herpes control on the immune system
Simon Mallal, Australia
Herpes viruses and drug rash with eosinophilia and systemic symptoms (DRESS)
Vincent Descamps, France
Herpes viruses and multiple drug allergyLast updated: 22 February 2016 -
Infection & Allergy IG related presentations in Geneva Congress 2012
Saturday, 16 June 2012
14:00 - 15:30
From Innate immunity to allergy
Intestinal microbiota and allergic immune response
Charles Mackay, AustraliaSunday, 17 June 2012
07:30 - 08:15
Meet the Experts
Pre-registration required
Meet the Expert 8
Hypersensitivity to non-betalactam antibiotics
Maria Jose Torres, Spain
13:30 - 15:00Symposium
Novel epidemiological insights on asthma and infection
Respiratory virus in the inception of childhood asthma
Robert Lemanske, United States
Role of rhinovirus C in childhood asthma
Peter Le Souef, Australia
Bacterial colonisation as a risk factor for initiatiuon and expression
Hans Bisgaard, Denmark
15:30 - 17:00Symposium
How can anti-infective drugs influence allergic disease?
Antivirals
Peter Openshaw, United Kingdom
Antibiotics
Thibaut van Zele, Belgium
Antiparasitics
Maria Yazdanbakhsh, The Netherlands
15:30 - 17:00Symposium
Microbiota, nutrition and allergic diseases
Probiotics and prebiotics for the prevention and treatment
Matthias Kopp, Germany
15:30 - 17:00
JMA Scientific Symposium
Bronchiolitis and the infant immune system
Maggina Paraskevi, GreeceMonday, 18 June 2012
07:00 - 07:45
Meet the Experts
Pre-registration required
Meet the Expert 15
Vaccinations in allergic children
Christoph Gruber, Germany
09:00 - 10:30
Plenary Symposium 4
Revisiting the origins of allergy
How does the microenvironment shape the allergic response?
Stephen Holgate, United Kingdom
10:45 - 12:15
symposium
Understanding urticaria
Germs and worms in urticaria
Peter Schmid-Grendelmeier, Switzerland
13:30 - 15:00
Business Meeting
Interest Group Infections & Allergy
Opening lecture:
Clinical relevance of superantigens in allergic disease. Task force conclusions
Philippe Gevaert, Belgium
15:30 - 17:00Symposium
Viral mechanisms in airway inflammation
Innate immune mechanisms in viral bronchiolitis - from mouse to infant
Riny Janssen, The Netherlands
Interferon response in virus-induced asthma
Sebastian Johnston, united Kingdom
Viral and bacterial interactions: their role in driving airway inflammation
Chrysanthi Skevaki, Greece
15:30 - 17:00
Symposium
EAACI meets Russia
The interaction of RSV and epithelial cells in the lung
Musa Khaitov, RussiaTuesday, 19 June 2012
08:30 - 10:00
Meet the Expert 21
Environmental pressure on epigenetic changes
William Cookson, United Kingdom
13:00 - 13:30
Pro & Con 6
Probiotics and prebiotics can reduces the incidence of infantile eczema
Pro: Philippe Eigenmann, Switzerland
Con: Matthias Kopp, Germany
15:30 - 17:00Business Meeting
Asthma Section
Opening lecture:
Asthma exacerbation
Sebastian Johnston
15:30 - 17:00Business Meeting
Pediatrics SectionOpening lecture:
Prebiotics and probiotics in allergy prevention and treatment: true or false?
Hania Szajewska, Poland
Wednesday, 20 June 2012
08:30 - 10:00
Plenary Symposium 7
Risk factors for allergy
Infections at the inception of allergy
Nikos Papadopoulos, Greece
10:30 - 12:00
Symposium
Molecular profiling of allergy and inflammation
Immunoproteomics: inflammatory response to staphylococcal superantigens
Barbara Broker, Germany
Last updated: 17 October 2014
GO TO
FULLSCREEN
FULLSCREEN